Copyright Reports & Markets. All rights reserved.

Global MRI Contrast Agents Market Research Report 2021

Request for Sample of this report
Buy now

1 MRI Contrast Agents Market Overview

  • 1.1 Product Overview and Scope of MRI Contrast Agents
  • 1.2 MRI Contrast Agents Segment by Type
    • 1.2.1 Global MRI Contrast Agents Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Extracellular Fluid Agents
    • 1.2.3 Blood Pool Agents
    • 1.2.4 Hepatobiliary (Liver) Agents
  • 1.3 MRI Contrast Agents Segment by Application
    • 1.3.1 MRI Contrast Agents Sales Comparison by Application: (2021-2027)
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
  • 1.4 Global MRI Contrast Agents Market Size Estimates and Forecasts
    • 1.4.1 Global MRI Contrast Agents Revenue 2016-2027
    • 1.4.2 Global MRI Contrast Agents Sales 2016-2027
    • 1.4.3 MRI Contrast Agents Market Size by Region: 2016 Versus 2021 Versus 2027

2 MRI Contrast Agents Market Competition by Manufacturers

  • 2.1 Global MRI Contrast Agents Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global MRI Contrast Agents Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global MRI Contrast Agents Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers MRI Contrast Agents Manufacturing Sites, Area Served, Product Type
  • 2.5 MRI Contrast Agents Market Competitive Situation and Trends
    • 2.5.1 MRI Contrast Agents Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest MRI Contrast Agents Players Market Share by Revenue
    • 2.5.3 Global MRI Contrast Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 MRI Contrast Agents Retrospective Market Scenario by Region

  • 3.1 Global MRI Contrast Agents Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global MRI Contrast Agents Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America MRI Contrast Agents Market Facts & Figures by Country
    • 3.3.1 North America MRI Contrast Agents Sales by Country
    • 3.3.2 North America MRI Contrast Agents Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe MRI Contrast Agents Market Facts & Figures by Country
    • 3.4.1 Europe MRI Contrast Agents Sales by Country
    • 3.4.2 Europe MRI Contrast Agents Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific MRI Contrast Agents Market Facts & Figures by Region
    • 3.5.1 Asia Pacific MRI Contrast Agents Sales by Region
    • 3.5.2 Asia Pacific MRI Contrast Agents Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America MRI Contrast Agents Market Facts & Figures by Country
    • 3.6.1 Latin America MRI Contrast Agents Sales by Country
    • 3.6.2 Latin America MRI Contrast Agents Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa MRI Contrast Agents Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa MRI Contrast Agents Sales by Country
    • 3.7.2 Middle East and Africa MRI Contrast Agents Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 U.A.E

4 Global MRI Contrast Agents Historic Market Analysis by Type

  • 4.1 Global MRI Contrast Agents Sales Market Share by Type (2016-2021)
  • 4.2 Global MRI Contrast Agents Revenue Market Share by Type (2016-2021)
  • 4.3 Global MRI Contrast Agents Price by Type (2016-2021)

5 Global MRI Contrast Agents Historic Market Analysis by Application

  • 5.1 Global MRI Contrast Agents Sales Market Share by Application (2016-2021)
  • 5.2 Global MRI Contrast Agents Revenue Market Share by Application (2016-2021)
  • 5.3 Global MRI Contrast Agents Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Bayer
    • 6.1.1 Bayer Corporation Information
    • 6.1.2 Bayer Description and Business Overview
    • 6.1.3 Bayer MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Bayer Product Portfolio
    • 6.1.5 Bayer Recent Developments/Updates
  • 6.2 Bracco Imaging
    • 6.2.1 Bracco Imaging Corporation Information
    • 6.2.2 Bracco Imaging Description and Business Overview
    • 6.2.3 Bracco Imaging MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Bracco Imaging Product Portfolio
    • 6.2.5 Bracco Imaging Recent Developments/Updates
  • 6.3 Guerbet Group
    • 6.3.1 Guerbet Group Corporation Information
    • 6.3.2 Guerbet Group Description and Business Overview
    • 6.3.3 Guerbet Group MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Guerbet Group Product Portfolio
    • 6.3.5 Guerbet Group Recent Developments/Updates
  • 6.4 Hengrui Medicine
    • 6.4.1 Hengrui Medicine Corporation Information
    • 6.4.2 Hengrui Medicine Description and Business Overview
    • 6.4.3 Hengrui Medicine MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Hengrui Medicine Product Portfolio
    • 6.4.5 Hengrui Medicine Recent Developments/Updates
  • 6.5 Lantheus
    • 6.5.1 Lantheus Corporation Information
    • 6.5.2 Lantheus Description and Business Overview
    • 6.5.3 Lantheus MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Lantheus Product Portfolio
    • 6.5.5 Lantheus Recent Developments/Updates
  • 6.6 YRPG
    • 6.6.1 YRPG Corporation Information
    • 6.6.2 YRPG Description and Business Overview
    • 6.6.3 YRPG MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 YRPG Product Portfolio
    • 6.6.5 YRPG Recent Developments/Updates
  • 6.7 BeiLu Pharma
    • 6.6.1 BeiLu Pharma Corporation Information
    • 6.6.2 BeiLu Pharma Description and Business Overview
    • 6.6.3 BeiLu Pharma MRI Contrast Agents Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 BeiLu Pharma Product Portfolio
    • 6.7.5 BeiLu Pharma Recent Developments/Updates

7 MRI Contrast Agents Manufacturing Cost Analysis

  • 7.1 MRI Contrast Agents Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of MRI Contrast Agents
  • 7.4 MRI Contrast Agents Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 MRI Contrast Agents Distributors List
  • 8.3 MRI Contrast Agents Customers

9 MRI Contrast Agents Market Dynamics

  • 9.1 MRI Contrast Agents Industry Trends
  • 9.2 MRI Contrast Agents Growth Drivers
  • 9.3 MRI Contrast Agents Market Challenges
  • 9.4 MRI Contrast Agents Market Restraints

10 Global Market Forecast

  • 10.1 MRI Contrast Agents Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of MRI Contrast Agents by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of MRI Contrast Agents by Type (2022-2027)
  • 10.2 MRI Contrast Agents Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of MRI Contrast Agents by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of MRI Contrast Agents by Application (2022-2027)
  • 10.3 MRI Contrast Agents Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of MRI Contrast Agents by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of MRI Contrast Agents by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Extracellular Fluid Agents
    Blood Pool Agents
    Hepatobiliary (Liver) Agents

    Segment by Application
    Hospitals
    Clinics

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    U.A.E

    By Company
    Bayer
    Bracco Imaging
    Guerbet Group
    Hengrui Medicine
    Lantheus
    YRPG
    BeiLu Pharma

    Buy now